经肝动脉化疗栓塞术联合索拉非尼治疗原发性肝癌患者疗效与生存分析

doi:10.3969/j.issn.1672-5069.2016.03.028

Abstract

Chen Fei,He Lulu,Wang Shan,et al.. Combination of sorafenib and transcatheter arterial chemoembolization in treatment of patients with primary liver cancer[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(3): 356-357.

References

[1] Willatt JM，Francis IR，Novelli PM，et al. Interventional therapies for hepatocellular carcinoma. Cancer Imaging，2012，12（1）：79-88.
[2] Crissien AM，Frenette C. Current management of hepatocellular carcinoma. Gastroenterol Hepatol，2014，10（3）：153-161.
[3] 荚卫东. 根治性肝切除联合索拉非尼治疗肝细胞癌的研究进展. 世界华人消化杂志，2012，20（22）：2019-2023.
[4] Chiu J，Tang YF，Yao TJ，et al． The use of single -agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis:a retrospective analysis of efficacy，safety，and survival benefits．Cancer，2012，118:5293-5301．
[5] Abou-Alfa GK，Amadori D，Santoro A，et al. Safety and efficacy of sorafenib in patients with hepatocellular carcinoma and Child-Pugh A versus B cirrhosis. Gastrointest Cancer Res，2011，4（2）：40-44.
[6] 廖毓菁，黄静，胡晓云，等. 原发性肝癌患者临床诊疗现状分析及多学科协作诊疗的初步探讨.实用肝脏病杂志，2015，18（5）：512-516.
[7] 张艳梅；崔红利；颜綦先，等. CIK细胞疗法联合TACE治疗原发性肝癌患者临床疗效观察. 实用肝脏病杂志，2015，18（6）：647-650.
[8] 张岚，任正刚. 索拉菲尼治疗肝癌常见不良反应及处理的研究进展. 中国肿瘤临床，2013，40（20）：1268-1271.
[9] 王峻峰，莫一我，王彦坤，等. 第一肝门不同阻断方式在精准肝切除中的应用. 昆明医科大学学报，2013，34（8）：51-53.
[10] 陈俊伟，庞鹏飞，孟晓春，等. TACE 联合索拉非尼治疗原发性肝癌合并不同分型门静脉癌栓的临床观察. 中华医学杂志，2013，93:663-667．
[11] 姚雪松，闫东，刘德忠，等. mＲECIST 标准与ＲECIST标准评价经动脉化疗栓塞联合索拉非尼治疗不可切除肝细胞癌疗效的比较．中华肝胆外科志，2013，19:332-336．
[12] 殷欣，张博恒，陈晓泓，等. 115例混合型肝癌临床病理特征及预后分析. 中华消化杂志，2011，31（2）:73-76.
[13] 金少纯．原发性肝癌血管介入治疗65例的临床研究．中外医疗，2011，19（1）：66-67．
[14] 孙建，简志祥，区应亮，等．术后预防性TACE对具有不同高危复发因素肝癌患者的临床价值. 实用医学杂志，2011，27（12）：2148-2150．
[15] 张岚，任正刚，干育红，等. 索拉非尼治疗不能手术的原发性肝细胞癌的疗效及预后因素. 中华肿瘤杂志，2010，32（8）：630-632.

Combination of sorafenib and transcatheter arterial chemoembolization in treatment of patients with primary liver cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Huang Shiying, Liang Shuang, Wei Yanghui, et al. Efficacy of CAO chemotherapy regimen combined with high frequency focused ultrasound ablation in the treatment of children with hepatoblastoma at stage III/IV [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 569-572.
[2]	Xing Diankui, Cheng Jing. Clinical value of ¹⁸F-FDG PET/CT scan in patients with hepatocellular carcinoma and hepatic microvascular invasion [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 252-254.
[3]	Wang Xiuqing, Ma Yanjun, Zhan Jinli. Efficacy of transcatheter arterial chemoembolization and ultrasound-guided microwave ablation in the treatment of patients with hepatocellular carcinoma at special sites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 260-263.
[4]	Zhang Xiaozhou, Shuai Ling, Wang Qingda, Yang Nan. Changes of serum miR-335 levels in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 268-271.
[5]	Zheng Xu，Qiu Xiong，Shao Zeyong，Luo Wenjie, Tang Shixiao. Changes of serum CEMIP, CA19-9 and CA242 levels in patients with pancreatic cancer and their clinical significance [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 280-284.
[6]	Chen Xiang, Wang Baolin, Wu Chen, et al.. Efficacy of transcatheter arterial chemoembolization and radion implantation in the treatment of patients with primary liver cancer and its impact on hepatic expressions of TRF1 and TRF2 [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 121-124.
[7]	Wang Hua, Zhao Yaning.. Efficacy and safety of sorafenib in the treatment of patients with advanced primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 936-939.
[8]	Ye Xuan, Zhang Peng.. Efficacy of microwave ablation combined with transcatheter arterial chemoembolization in treatment of patients with hepatic metastasis from colorectal cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 955-958.
[9]	Meng Lingjun, Zhang Xiaorong, Yang Baojin.. Abdominal aortic lymph node clearance improves progression-free and overall survival in patients with type I and II hilar cholangiocarcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 761-764.
[10]	Jin Juan, Zhou Shoulin, Gao Jing, et al.. Application of dignity therapy combined with psychological intervention in patients with end-stage primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 805-806.
[11]	Yang Zhijun, Zhao Lijuan. Application of superb micro-vascular imaging in the evaluation of blood suply in intrahepaitc lesions in patients with primary liver cancer underwent TACE [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 509-512.
[12]	Chang Xidong, Huang Jun, He Wentao. Survival of primary liver cancer patients with spontaneous rupture after emergent hepatectomy or TACE [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 633-634.
[13]	Song Linquan, Liang Zhihong. Application of high frequency electric knife in hepatectomy in the treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 637-638.
[14]	Liu Kui, Zhang Jianfeng, Wang Ying, et al. Survival of children with hepatoblastma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 647-648.
[15]	Xu Jian, Zhang Hao, Yu Xiaojiong. Factors influencing long-term survival in patients with hepatocellular carcinoma with underlying hepatitis B virus infection after hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 426-430.